Suture Anchor Devices Market Size & Share 2025 - 2034

Suture Anchor Devices Market Size

The global suture anchor devices market was valued at USD 764 million in 2024 and is projected to grow from USD 793.9 million in 2025 to USD 1.19 billion by 2034, expanding at a CAGR of 4.7%. This steady growth is stimulated by the rising number of sports-related injuries.

According to the National Safety Council (NSC), in 2023 alone, approximately 3.7 million people were treated in emergency departments for injuries involving sports and recreational equipment. Activities such as exercise, cycling, and basketball are among the leading causes of these injuries, many of which result in damage to tendons and ligaments.
 

As a result, procedures such as rotator cuff repair, achilles tendinosis treatment, and cruciate ligament reconstruction all of which commonly utilize suture anchor devices are increasingly performed to restore function and alleviate symptoms in affected individuals. A suture anchor device is a specialized orthopedic implant designed to attach soft tissue such as tendons and ligaments to bone during surgical procedures. Major companies in the industry include Arthrex, Smith & Nephew, Stryker and Zimmer Biomet.
 

The market increased from USD 685.8 million in 2021 to USD 736.1 million in 2023 reflecting a steady rise in demand for orthopedic solutions. This growth is primarily escalated by the increasing prevalence of age-related musculoskeletal conditions, which include disorders of bones, joints, muscles, and connective tissues. As individuals age, they face a higher risk of tendon degeneration, ligament tears, and joint instability, often requiring surgical intervention using suture anchor devices. According to the World Health Organization (WHO), approximately 1.71 billion people worldwide are affected by musculoskeletal conditions, making them the leading cause of disability globally. These conditions frequently result in chronic pain and reduced mobility, prompting the need for reliable and effective surgical suture repair options.
 

In addition to the clinical burden, the expanding geriatric population is a major demographic force shaping the future of the suture anchor device market. The WHO projects that the number of people aged 60 and above will reach 2.1 billion by 2050, up from 1.4 billion by 2030. This aging population is increasingly seeking minimally invasive treatments that offer faster recovery and improved quality of life. As healthcare systems adapt to serve older adults more effectively, the demand for advanced suture anchor technologies featuring biocompatibility, ease of use, and reduced surgical trauma is expected to grow. These innovations are helping shift orthopedic care toward more patient-centric and outpatient-friendly solutions, further accelerating market expansion.
 

Suture anchor devices are an integral part of modern orthopedic and sports medicine procedures. These are specialized implants designed to attach soft tissue such as tendons and ligaments to bone during surgical repairs. They come in various forms each suited to specific clinical needs. With advancements in material science and surgical techniques, suture anchors now offer enhanced fixation strength, biocompatibility, and ease of use. Their role is critical in minimally invasive surgeries, where precision and tissue preservation are key to successful outcomes.
 

Suture Anchor Devices Market Trends

• The global suture anchor device market is evolving rapidly, shaped by both clinical demands and technological innovation. At a macro level, the rise in sports-related injuries and age-associated musculoskeletal conditions is fueling demand for advanced soft tissue fixation solutions. Minimally invasive orthopedic procedures, especially arthroscopic surgeries, are becoming standard, enabling faster recovery and reduced hospital stays.
   
• Technological advancements in anchor design are transforming surgical outcomes. Innovations such as knotless anchors, bioabsorbable composites, and radiolucent PEEK materials are improving fixation strength, reducing tissue trauma, and enhancing compatibility with imaging systems. For example, bioabsorbable PEEK anchors now offer controlled degradation and improved tissue integration.
   
• Moreover, AI and robotic-assisted surgery are entering orthopedic workflows, enabling greater precision in anchor placement and reducing variability in outcomes. Platforms such as SurgicAI are training robotic systems to perform complex suturing tasks with minimal human input, using reinforcement and imitation learning to replicate expert techniques.
   
• Furthermore, manufacturers are investing in clinician training, smart instrumentation, and bioengineering, aiming to meet the growing demand for patient-specific, minimally invasive orthopedic care. With healthcare systems emphasizing efficiency and recovery, suture anchor devices are evolving into precision tools that support personalized treatment and scalable surgical solutions across diverse clinical environments.
   

Suture Anchor Devices Market Analysis

Based on the product, the market is segmented into absorbable and non-absorbable. The non-absorbable segment led this market in 2024, accounting for the highest market share because of its superior mechanical strength, long-term fixation capabilities. This segment was valued at USD 426.1 million in 2024 and is projected to reach USD 658 million by 2034, growing at a CAGR of 4.5%.
 

This growth is because of the preference for non-absorbable suture anchors in procedures requiring permanent structural support across hospitals and surgical centers. In comparison, the absorbable suture anchor devices segment, valued at USD 337.9 million in 2024, is expected to grow to USD 539.1 million by 2034, with a slightly higher CAGR of 4.9%, supported by increasing surgeon preference for biologically integrated solutions, advancements in bio-composite materials, and the growing adoption of minimally invasive procedures.
 

• Non-absorbable suture anchors led the global market in 2024, primarily due to their high mechanical strength, long-term fixation capabilities, and reliability in high-load orthopedic procedures such as rotator cuff and labral repairs.
   
• A major driver for this segment is the increasing use of durable materials such as PEEK and titanium, which offer biocompatibility, radiolucency, and consistent performance. These anchors are preferred in surgeries requiring permanent structural support, especially in complex reconstructions and sports-related injuries.
   
• For instance, Anika Therapeutics X-Twist suture anchor is designed for secure soft tissue fixation using non-absorbable materials such as PEEK. These anchors support high pullout strength, simple deployment, and compatibility with various surgical techniques, making them ideal for demanding orthopedic applications.
   
• The segment is also benefiting from its integration with robotic-assisted and AI-guided surgical platforms, which require anchors with predictable mechanical behavior and stable fixation properties. This compatibility enhances surgical precision and reduces variability in outcomes.
   
• Overall, the non-absorbable suture anchor segment is expected to grow, driven by material innovation, clinical reliability, and the growing demand for durable fixation solutions across hospitals and ambulatory surgical centers.
   

Based on the material, the suture anchor devices market is segmented into metallic suture anchor, bio absorbable suture anchor, polyether ether ketone (peek) suture anchor, bio composite suture anchor, and all soft suture anchor. The polyether ether ketone (peek) suture anchor segment accounted for the highest market share of 28.8% in 2024.
 

• The dominance of PEEK in the suture anchor market is driven by its strong clinical performance, safety profile and surgeon preference. Its non-metallic nature, excellent strength and radiolucency make it a preferred choice in orthopedic surgeries especially for procedures involving the shoulder, knee and hips.
   
• In an article published in 2022 by PubMed; PEEK knotless anchors were compared to biodegradable anchors for shoulder repairs in patients. After a follow up of 3-5 years it was observed that there was no significant difference between the two groups that were tested for PEEK knotless anchors and biodegradable anchors, highlighting that the PEEK suture anchors are safe and can be used for long terms.
   
• Conversely, the bio absorbable suture anchor segment is expected to expand to the highest CAGR of 5.5%. These suture anchors are preferred by surgeons that degrade naturally, eliminating the need for removal and reducing long-term complications. Bioabsorbable anchors also support tissue regeneration, making them ideal for younger and active patients.
   

Based on the tying type, the suture anchor devices market is segmented into knotless suture anchor and knotted suture anchors. The knotless suture anchor segment accounted for the highest market share of 56.2% in 2024.
 

• The knotless suture segment has emerged as the leading category in the typing type. This dominance is driven by its ability to deliver uniform tension, reduced operative time and improved ease of use, especially during minimally invasive arthroscopic procedures.
   
• In 2024, a clinical study published on PubMed reported that patients who underwent arthroscopic hip labral repair with knotless suture anchors had slightly better postoperative outcomes. They demonstrated reduced incidence of postoperative synovitis, compared to patients treated with traditional knot tying anchors. This reinforced knotless anchor advantage in both clinical efficacy and patient recovery.
   
• Additional studies have shown that knotless anchors reduce average surgery time and eliminate issues related to knot bulk and soft tissue irritation.
   
• In contrast, the knotted suture anchor segment continues to serve traditional surgical preferences but are increasingly seen as less efficient due to longer operation times. Hence more hospitals and orthopedic centers are shifting towards knotless suture anchor as a standard of care, especially in sports medicine and hip arthroscopy.
   

Based on the application, suture anchor devices market is segmented into rotator cuff repair, archilles tendinosis repair, cruciate ligament repairs, biceps tenodesis and other applications. The rotator cuff repair segment accounted for the highest market share of 35.2% in 2024.
 

• The rotator cuff repair segment is supported by the rising prevalence of shoulder injuries and growing adoption of minimally invasive arthroscopic techniques.
   
• Since life expectancy has increased globally, the burden of degenerative tendon injuries particularly rotator cuff tears have expanded escalating demand for reliable fixation methods. Rotator cuffs injuries are among the most common musculoskeletal disorders in people.
   
• Conversely, the archilles tendinosis repair segment is expected to expand to the highest CAGR of 5.4%. Achilles tendon injuries are increasingly common among athletes and active individuals, especially in sports involving running, jumping, and sudden directional changes. The rising participation in recreational and competitive sports globally is driving demand for effective and durable repair solutions.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the suture anchor devices market is segmented into hospital and clinics, ambulatory surgical centres and other end users. The hospital and clinics segment accounted for the highest market share of 56.2% in 2024.
 

• The hospitals and clinics segment held the largest market share in the suture anchor device market due to the high volume of orthopedic procedures performed in these settings. Hospitals are the primary centers for sports injury treatment, joint reconstruction, and tendon repair surgeries, making them the largest users of suture anchor systems.
   
• This segment benefits from large patient inflows, government-supported healthcare programs, and integrated surgical infrastructure, which support the adoption of advanced anchor technologies including knotless, bioabsorbable, and robotic-compatible systems.
   
• Additionally, the ambulatory surgical centres, accounting for 24.8% market share in 2024, are expanding due to the growing demand for outpatient orthopedic procedures. These centers are increasingly preferred for minimally invasive surgeries.
   

North America dominated the global suture anchor devices market with the highest market share of 42.5% in 2024. The region has advanced healthcare infrastructure, and the rate of adoption of innovative orthopedic technologies is also high. Further, there is a high prevalence of musculoskeletal disorders in U.S. and Canada, due to sports-related injuries, and age-associated tendon degeneration, all of which drive demand for suture anchor systems.
 

• The U.S. market was valued at 270.1 million and USD 279.4 million in 2021 and 2022, respectively. In 2024 the market size reached USD 299.8 million from USD 289.2 million in 2023.
   
• A major contributor to this growth is the high incidence of rotator cuff injuries. According to Brown Health as reported in 2020, between 400,000 to 500,000 rotator cuff repairs are performed each year in the United States, and this number is expected to increase over the coming years. Each procedure typically involves multiple suture anchors, significantly boosting device demand.
   
• The U.S. also leads in the adoption of advanced orthopedic technologies, including robotic-assisted surgery, bioabsorbable materials, and PEEK-based anchors, supported by a well-regulated approval process and strong research and development investment from major players.
   
• Moreover, the process of regulatory approvals is regularized in developed countries such as the U.S., and the country also has high public awareness and robust research and development investment.
   
• Thus, as there is growing demand, the market is expected to see sustained revenue growth through 2030, driven by both public health initiatives and private sector innovation.
   

Europe suture anchor devices market accounted for USD 205.9 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• In Europe, musculoskeletal conditions (MSC) are the leading cause of chronic pain, disability and reduced quality of life across region. Approximately 1in 3 Europeans, that is 150 individuals suffering from MSC, with back pain, joint disease and osteoporosis as the most common complaints, as reported by NIH. The prevalence of these conditions rise sharpy with age making them dominant in the region’s growing elderly population.
   
• MSCs are the primary cause of years lived with disability in Europe. They are also the most prevalent work-related health issue, with three out of five workers reporting musculoskeletal problems.
   
• These conditions place a heavy demand on healthcare infrastructure, also the direct healthcare cost for MSCs and injuries account for the largest expenditure in many European healthcare systems.
   

Germany suture anchor devices market is projected to experience steady growth between 2025 and 2034.
 

• The market in Germany is evolving due to changing surgical preferences and steady aging population. A 2025 study published in the journal of shoulder and elbow surgery highlights a sharp rise in reverse total shoulder arthroplasty (rTSA) procedures, particularly in elderly patients.
   
• rTSA is a modern shoulder replacement technique that restore movement, it continues to support the market growth for suture anchor devices as many rTSA procedures still require soft tissue fixation.
   
• Since, the number of surgeries increase the use of anchors continues to drive consistent demand.
   

The Asia Pacific region is projected to be valued at USD 177.1 million in 2025 and is expected to reach USD 282.3 million by 2034.
 

• The region is expected to witness the fastest CAGR in the suture anchor device market due to rising awareness of minimally invasive orthopedic procedures, expanding government-backed healthcare initiatives, and increasing disposable incomes. Additionally, the growing elderly population and improving insurance coverage are driving demand for orthopedic treatments, including those requiring suture anchor devices.
   
• In Asia Pacific, the number of older persons is projected to increase from 630 million in 2020 to about 1.3 billion by 2050. By 2050, one quarter of the population will be 60 or older.
   

Japan suture anchor devices market is poised to witness lucrative growth between 2025 – 2034.
 

• The country’s aging demographic is a major driver, with 29.1% of the population aged 65 and older as of 2023, according to Statista. This trend is increasing demand for orthopedic interventions, particularly for age-related musculoskeletal conditions, thereby boosting adoption of suture anchor devices in surgical procedures.
   
• Government initiatives and public awareness campaigns are enhancing access to orthopedic care and rehabilitation services, positioning Japan as a key player in the Asia-Pacific orthopedic device landscape.
   

Brazil is experiencing significant growth in the suture anchor devices market, driven by its focus on musculoskeletal health.
 

• In Brazil, the rising burden of chronic musculoskeletal conditions often linked to aging and lifestyle factors is accelerating demand for orthopedic solutions, including suture anchor devices used in minimally invasive surgeries. As the healthcare system increasingly prioritizes early intervention and long-term mobility, the adoption of advanced surgical tools is gaining momentum.
   
• Additionally, Brazil’s aging population is contributing to increased orthopedic care needs. As per the Brazilian Institute of Geography and Statistics, the number of individuals aged 65 and older reached 22.17 million in 2022, accounting for 10.9% of the total population, a 57.4% increase since 2010. This demographic shift is driving demand for joint repair and ligament reconstruction procedures, positioning Brazil as a key emerging market in Latin America for suture anchor device technologies.
   

The suture anchor devices market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia's elderly population is rising at a much faster pace than any other segment. It is estimated that the population aged 60 years and above will grow from 2 million (5.9% of the total population) in 2020 to 10.5 million by 2050.
   
• This demographic shift is expected to significantly increase demand for orthopedic care, as older individuals are more prone to degenerative joint conditions and musculoskeletal injuries.
   
• As a result, the adoption of suture anchor devices for minimally invasive orthopedic procedures is projected to grow, positioning Saudi Arabia as a promising market in the Middle East for advanced orthopedic technologies.
   

Suture Anchor Devices Market Share

• The top 5 players, such as Arthrex, Smith & Nephew, Stryker, Zimmer Biomet and Johnson & Johnson, collectively held 65% of the total market share. These companies maintain their leadership through a combination of technological innovation, including advancements in bioabsorbable and knotless anchor systems, integration of AI-assisted surgical planning, consistent regulatory approvals, and strategic partnerships with hospitals, sports medicine centers, and orthopedic specialists. Their strong research and development capabilities and global distribution networks continue to reinforce their competitive edge in this rapidly evolving market.
   
• Arthrex is the leading player in the market, with a strong portfolio of innovative products designed for minimally invasive orthopedic procedures. Its advanced anchor systems, including bioabsorbable and knotless technologies, offer high efficiency, precision, and compatibility with arthroscopic platforms, making them a preferred choice for high-volume orthopedic centers and sports medicine clinics.
   
• Meanwhile, emerging competitors such as Ossio and MJ Surgical are gaining traction by introducing cost-effective and biocompatible solutions. These companies are addressing unmet needs in low-resource settings, regional hospitals, and specialized orthopedic practices by offering versatile anchor systems and simplified surgical workflows.
   
• To increase market share, companies are launching cost-effective suture anchor devices with improved fixation strength, durability, and ease of use across a range of orthopedic procedures. Innovations in material composition, such as bioabsorbable and composite anchors, along with enhancements in surgical precision and quality control.
   

Suture Anchor Devices Market Companies

Few of the prominent players operating in the suture anchor devices industry include:
 

• Anika Therapeutics
• Arthrex
• ConMed
• Enovis Corporation
• Fuse Medical
• Johnson & Johnson
• MJ Surgical
• NeoSys
• Orthomed
• Ossio
• Parcus Medical
• SBM
• Smith & Nephew
• Stryker Corporation
• Teknimed
• Tulpar Medical Solutions
• Zimmer Biomet
   
• Johnson & Johnson

Johnson & Johnson, through its DePuy Synthes division, is a key player in the orthopedic devices market, offering a wide range of suture anchor systems for sports medicine and trauma procedures. The company leverages its global scale, clinical research capabilities, and surgeon partnerships to deliver reliable, high-performance anchor solutions. Its focus on procedural efficiency and integration with broader orthopedic systems makes it a preferred choice in both hospital and outpatient settings.
 

• Zimmer Biomet

Zimmer Biomet is known for its comprehensive orthopedic portfolio, including advanced suture anchor devices designed for shoulder, knee, and hip repairs. The company emphasizes innovation in anchor design, offering both bioabsorbable and non-absorbable options to meet diverse surgical needs. With a strong presence in global markets and a focus on surgeon education and training, Zimmer Biomet continues to strengthen its position in sports medicine and soft tissue repair segments.
 

• MJ Surgical

MJ Surgical is an emerging manufacturer based in India, offering cost-effective and reliable orthopedic solutions, including suture anchor devices. The company focuses on affordability without compromising quality, making it a strong contender in price-sensitive and developing markets. MJ Surgical’s growing export footprint and commitment to manufacturing excellence are helping it gain recognition in the global orthopedic device landscape.
 

Suture Anchor Devices Industry News:

• In January 2024, Paragon 28 (acquired by Zimmer Biomet) launched the Grappler Knotless Anchor System and Bridgeline Tape, expanding its soft tissue repair portfolio for foot and ankle procedures. The Grappler system was designed to provide strong fixation without the need for knot tying, while Bridgeline Tape offered enhanced tissue compression and load distribution. This launch improved surgical efficiency and outcomes, reinforcing Paragon 28’s commitment to innovation in orthopedic solutions.
   
• In December 2022, Stryker launched the Citrefix Suture Anchor System, designed specifically for foot and ankle surgical procedures. The system featured Citregen, an award-winning bioresorbable material engineered to mimic native bone chemistry and structure. This innovation supported bone regeneration and reduced chronic inflammation, offering improved healing outcomes. The launch marked a significant expansion of Stryker’s Citregen portfolio and reinforced its commitment to advancing orthopedic surgical technologies.
   

The suture anchor devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Absorbable
• Non absorbable

Market, By Material

• Metallic suture anchor
• Bio absorbable suture anchor
• Polyether ether ketone (PEEK) suture anchor
• Bio composite suture anchor
• All soft suture anchor

Market, By Tying Type

• Knotless suture anchor
• Knotted suture anchor

Market, By Application

• Rotator cuff repair
• Archilles tendinosis repair
• Cruciate ligament repairs
• Biceps tenodesis
• Other applications

Market, By End Use

• Hospital and clinics
• Ambulatory surgical centres
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE